CompuGroup Medical Societas Europaea develops and sells software and information technology services for healthcare sector worldwide.
Reasonable growth potential with mediocre balance sheet.
Share Price & News
How has CompuGroup Medical Societas Europaea's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: COMPG has not had significant price volatility in the past 3 months.
7 Day Return
CH Healthcare Services
1 Year Return
CH Healthcare Services
Return vs Industry: COMPG exceeded the Swiss Healthcare Services industry which returned -11.3% over the past year.
Return vs Market: COMPG exceeded the Swiss Market which returned -5.3% over the past year.
Price Volatility Vs. Market
How volatile is CompuGroup Medical Societas Europaea's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is CompuGroup Medical Societas Europaea undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: COMPG (CHF67.8) is trading above our estimate of fair value (CHF47.17)
Significantly Below Fair Value: COMPG is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: COMPG is poor value based on its PE Ratio (46.2x) compared to the Healthcare Services industry average (39.2x).
PE vs Market: COMPG is poor value based on its PE Ratio (46.2x) compared to the Swiss market (16.2x).
Price to Earnings Growth Ratio
PEG Ratio: COMPG is poor value based on its PEG Ratio (2.9x)
Price to Book Ratio
PB vs Industry: COMPG is overvalued based on its PB Ratio (11.7x) compared to the XE Healthcare Services industry average (3.3x).
How is CompuGroup Medical Societas Europaea forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: COMPG's forecast earnings growth (16.2% per year) is above the savings rate (-0.6%).
Earnings vs Market: COMPG's earnings (16.2% per year) are forecast to grow faster than the Swiss market (8.3% per year).
High Growth Earnings: COMPG's earnings are forecast to grow, but not significantly.
Revenue vs Market: COMPG's revenue (5.3% per year) is forecast to grow faster than the Swiss market (2.2% per year).
High Growth Revenue: COMPG's revenue (5.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: COMPG's Return on Equity is forecast to be high in 3 years time (31.3%)
How has CompuGroup Medical Societas Europaea performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: COMPG has high quality earnings.
Growing Profit Margin: COMPG's current net profit margins (8.5%) are lower than last year (13.1%).
Past Earnings Growth Analysis
Earnings Trend: COMPG's earnings have grown significantly by 21.2% per year over the past 5 years.
Accelerating Growth: COMPG's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: COMPG had negative earnings growth (-31.5%) over the past year, making it difficult to compare to the Healthcare Services industry average (-4.6%).
Return on Equity
High ROE: Whilst COMPG's Return on Equity (25.45%) is high, this metric is skewed due to their high level of debt.
How is CompuGroup Medical Societas Europaea's financial position?
Financial Position Analysis
Short Term Liabilities: COMPG's short term assets (€232.9M) do not cover its short term liabilities (€236.3M).
Long Term Liabilities: COMPG's short term assets (€232.9M) do not cover its long term liabilities (€569.6M).
Debt to Equity History and Analysis
Debt Level: COMPG's debt to equity ratio (179.9%) is considered high.
Reducing Debt: COMPG's debt to equity ratio has reduced from 209% to 179.9% over the past 5 years.
Debt Coverage: COMPG's debt is well covered by operating cash flow (23.6%).
Interest Coverage: COMPG's interest payments on its debt are well covered by EBIT (25.8x coverage).
Inventory Level: COMPG has a low level of unsold assets or inventory.
Debt Coverage by Assets: COMPG's debt is not covered by short term assets (assets are 0.5x debt).
What is CompuGroup Medical Societas Europaea's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: COMPG's dividend (0.8%) isn’t notable compared to the bottom 25% of dividend payers in the Swiss market (2.05%).
High Dividend: COMPG's dividend (0.8%) is low compared to the top 25% of dividend payers in the Swiss market (4.44%).
Stability and Growth of Payments
Stable Dividend: COMPG is not paying a notable dividend for the Swiss market, therefore no need to check if payments are stable.
Growing Dividend: COMPG is not paying a notable dividend for the Swiss market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: COMPG is not paying a notable dividend for the Swiss market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of COMPG's dividend in 3 years as they are not forecast to pay a notable one for the Swiss market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Frank Gotthardt (69yo)
Mr. Frank Gotthardt has been the Chairman of Management Board and Chief Executive Officer of CompuGroup Medical Societas Europaea (formerly, CompuGroup Holding AG) since July 1, 2008. He has been Chairman ...
CEO Compensation Analysis
Compensation vs Market: Frank's total compensation ($USD4.34M) is above average for companies of similar size in the Swiss market ($USD2.06M).
Compensation vs Earnings: Frank's compensation has been consistent with company performance over the past year.
|Chairman of Management Board & CEO||11.75yrs||€4.02m||37% €1.2b|
|Member of Executive Board||1.42yrs||€736.88k||no data|
|Chief Process Officer & Member of Management Board||5yrs||€589.15k||0.0027% €85.1k|
|Member of Executive Board||1.42yrs||€761.19k||no data|
|Director of CHS Consumer & Health Management Services and Member of the Management Board||0.42yr||€473.51k||no data|
|CFO & Member of Management Board||0.67yr||no data||no data|
|Head of Investor Relations||no data||no data||no data|
|Senior Vice President of Northern America & Canada||3.25yrs||no data||no data|
|Chief Communication Officer of Political & Public Affairs||no data||no data||no data|
|Senior Vice President of Asian & African Region||5.25yrs||no data||no data|
Experienced Management: COMPG's management team is considered experienced (2.3 years average tenure).
|Member of Supervisory Board||5.92yrs||€90.00k||0.29% €9.3m|
|Independent Member of Supervisory Board||2.17yrs||€60.00k||no data|
|Deputy Chairman of Supervisory Board||no data||€60.00k||7.38% €236.9m|
|Member of Medical Advisory Board||no data||no data||no data|
|Independent Member of Supervisory Board||2.92yrs||€60.00k||no data|
|Employee Representative Supervisory Board Member||4.17yrs||€60.00k||no data|
|Employee Representative Supervisory Board Member||4.17yrs||€60.00k||no data|
Experienced Board: COMPG's board of directors are considered experienced (4.2 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
CompuGroup Medical Societas Europaea's company bio, employee growth, exchange listings and data sources
- Name: CompuGroup Medical Societas Europaea
- Ticker: COMPG
- Exchange: SWX
- Founded: 1979
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: €3.043b
- Listing Market Cap: €3.211b
- Shares outstanding: 48.41m
- Website: https://www.cgm.com
Number of Employees
- CompuGroup Medical Societas Europaea
- Maria Trost 21
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|COP||DB (Deutsche Boerse AG)||Yes||Common Shares||DE||EUR||Jul 1996|
|0MSD||LSE (London Stock Exchange)||Yes||Common Shares||GB||EUR||Jul 1996|
|CMPV.F||OTCPK (Pink Sheets LLC)||Yes||Common Shares||US||USD||Jul 1996|
|COP||XTRA (XETRA Trading Platform)||Yes||Common Shares||DE||EUR||Jul 1996|
|COPD||BATS-CHIXE (BATS 'Chi-X Europe')||Yes||Common Shares||GB||EUR||Jul 1996|
|COP||WBAG (Wiener Boerse AG)||Yes||Common Shares||AT||EUR||Jul 1996|
|COMPG||SWX (SIX Swiss Exchange)||Yes||Common Shares||CH||CHF||Jul 1996|
|COP||ETLX (Eurotlx)||Yes||Common Shares||IT||EUR||Jul 1996|
|COP1 N||BMV (Bolsa Mexicana de Valores)||Yes||Common Shares||MX||MXN||Jul 1996|
CompuGroup Medical Societas Europaea develops and sells software and information technology services for healthcare sector worldwide. The company’s Ambulatory Information Systems segment provides practice management software and electronic medical records for office-based physicians, dentists, medical care centers, and physician's networks. This segment offers integrated software solutions for customers to manage, analyze, and use medical data; organize business operations; and generate invoices. Its Pharmacy Information Systems segment provides integrated clinical, administrative, and financial software applications for retail pharmacies. This segment also offers in-store and online merchandising programs. The company’s Hospital Information Systems segment provides clinical and administrative solutions for the inpatient sector. This segment serves acute hospitals; rehabilitation centers; and social services, including multi-site hospital networks and regional care organizations. Its Health Connectivity Services segment provides solutions that enable pharmaceutical companies to provide information to healthcare providers through software interfaces. This segment also offers clinical decision support systems, and drugs and therapy databases for healthcare providers; and solutions for personal health records, consumer portals, and mobile applications, as well as collects and mediates clinical data for market studies, clinical trials, etc. It serves pharmaceutical companies, health insurance companies, and other healthcare IT companies and consumers. The company was formerly known as CompuGroup Medical Aktiengesellschaft and changed its name to CompuGroup Medical Societas Europaea in February 2016. CompuGroup Medical Societas Europaea was founded in 1979 and is headquartered in Koblenz, Germany.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/04/05 01:59|
|End of Day Share Price||2020/04/03 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.